IMTX
Immatics N.V.
$9.98
-0.28 (-2.73%)
At close · Jul 8
Market Cap
$1.36B
Shares
136,673,161
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$9.98
Open$10.71
Day$9.85–10.89
52W$5.05–12.41
Avg vol 30d457K
Short int5.6M · 4.1% float · 9.0d
Short vol53%
DataJan 2020–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−1%
below
Price vs 50-day avg
−4%
below
RSI (14)
50
neutral
MACD trend
Positive
52-week position
67%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+8%
trailing
6-month return
+6%
trailing
YTD return
−5%
this year
Relative strength
−1%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $10 › 200d $10 — 50d above 200d
Institutional flow
Accumulating
+11% holders QoQ · +15 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
4.13% of float · ▲ +17.6% MoM · 9.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
84 holders — mid 3-yr range
Squeeze score
62
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
64%
annualized · 1-yr
Max drawdown
−28%
past year
ATR
5.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−1%
Neutral
Price vs 50-day avg
−4%
Neutral
RSI (14)
50
Neutral
MACD trend
Positive
Bullish
52-week position
67%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $10 › 200d $10 — 50d above 200d
Institutional flow
Accumulating
+11% holders QoQ · +15 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
4.13% of float · ▲ +17.6% MoM · 9.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
84 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $5
Now $10 · 67%
52-wk high $12
vs 200-day avg -1%
vs 50-day avg -4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IMTX
this stock
Immatics N.V.
|
$1.36B | -5.0% | — | — | 4.1% |
|
ONC
BeOne Medicines Ltd.
|
$436.30B | -0.6% | +22179.2% | 887.9 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.50B | +9.9% | +46.2% | 29.6 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.50B | -14.0% | +20.8% | 16.2 | 3.2% |
|
ARGX
Argenx SE
|
$57.20B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IMTX | -1.5% | +8.2% | +6.4% | -1.5% | -5.0% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -1.3% | +7.4% | -1.0% | -1.3% | -14.3% |